First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting

by Clumeck, Nathan, Mwamba, Claude, Kabeya, Kabamba, Matanda, Serge, Vaira, Dolorès, Necsoi, Coca, Kadiebwe, David, Delforge, Marc, Kasamba, Eric, Milolo, Chantal, Ilunga, Joe, Kapend, Liévin
Published 2014

Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors

by Kumar, Amit, Abbas, Wasim, Bouchat, Sophie, Gatot, Jean-Stéphane, Pasquereau, Sébastien, Kabeya, Kabamba, Clumeck, Nathan, De Wit, Stéphane, Van Lint, Carine, Herbein, Georges
Published 2016

First-line therapy with LPV/r vs NVP and 2 NRTIs in a developing country: W144 of a randomized trial

by Clumeck, Nathan, Mwamba, Claude, Kabeya, Kabamba, Calvez, Vincent, Matanda, Serge, Vaira, Dolorès, Peytavin, Gilles, Necsoi, Coca, Delforge, Marc, Kadiebwe, David, Milolo, Chantal, Ilunga, Joe, Kapend, Liévin
Published 2014

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1

by Bouchat, Sophie, Delacourt, Nadège, Kula, Anna, Darcis, Gilles, Van Driessche, Benoit, Corazza, Francis, Gatot, Jean‐Stéphane, Melard, Adeline, Vanhulle, Caroline, Kabeya, Kabamba, Pardons, Marion, Avettand‐Fenoel, Véronique, Clumeck, Nathan, De Wit, Stéphane, Rohr, Olivier, Rouzioux, Christine, Van Lint, Carine
Published 2015

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reacti...

by Darcis, Gilles, Kula, Anna, Bouchat, Sophie, Fujinaga, Koh, Corazza, Francis, Ait-Ammar, Amina, Delacourt, Nadège, Melard, Adeline, Kabeya, Kabamba, Vanhulle, Caroline, Van Driessche, Benoit, Gatot, Jean-Stéphane, Cherrier, Thomas, Pianowski, Luiz F., Gama, Lucio, Schwartz, Christian, Vila, Jorge, Burny, Arsène, Clumeck, Nathan, Moutschen, Michel, De Wit, Stéphane, Peterlin, B. Matija, Rouzioux, Christine, Rohr, Olivier, Van Lint, Carine
Published 2015

Comparison of Methods for In-House Screening of HLA-B*57:01 to Prevent Abacavir Hypersensitivity in HIV-1 Care

by De Spiegelaere, Ward, Philippé, Jan, Vervisch, Karen, Verhofstede, Chris, Malatinkova, Eva, Kiselinova, Maja, Trypsteen, Wim, Bonczkowski, Pawel, Vogelaers, Dirk, Callens, Steven, Ruelle, Jean, Kabeya, Kabamba, De Wit, Stephane, Van Acker, Petra, Van Sandt, Vicky, Emonds, Marie-Paule, Coucke, Paul, Sermijn, Erica, Vandekerckhove, Linos
Published 2015

Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line

by Kumar, Amit, Abbas, Wasim, Colin, Laurence, Khan, Kashif Aziz, Bouchat, Sophie, Varin, Audrey, Larbi, Anis, Gatot, Jean-Stéphane, Kabeya, Kabamba, Vanhulle, Caroline, Delacourt, Nadège, Pasquereau, Sébastien, Coquard, Laurie, Borch, Alexandra, König, Renate, Clumeck, Nathan, De Wit, Stephane, Rohr, Olivier, Rouzioux, Christine, Fulop, Tamas, Van Lint, Carine, Herbein, Georges
Published 2016